JABIL DL-,001/ US4663131039 /
11/06/2024 07:38:04 | Var. +0.15 | Volume | Denaro07:38:04 | Lettera07:38:04 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
108.05EUR | +0.14% | - Fatturato: - |
108.05Quantità in denaro: - | 109.10Quantità in lettera: - | 13.12 bill.EUR | - | - |
GlobeNewswire
07:00
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
GlobeNewswire
07:00
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockhol...
GlobeNewswire
07:00
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire
07:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
GlobeNewswire
06:00
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Newsfile Corp
05:22
"Winds of Change" Celebrating Kazakhstan's National Parks at The Canvas 3.0 Exhibition June 8th - Ju...
GlobeNewswire
05:16
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared g...
GlobeNewswire
04:50
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
04:19
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday